Gaziantep bölgesinde perikardiyal efüzyonlu hastaların klinik, laboratuvar ve ekokardiyografik özelliklerinin değerlendirilmesi
Kalbi çevreleyen perikardda sıvı miktarındaki artış perikardiyal efüzyon (PE) olarak adlandırılır. Primer perikardiyal hastalıklara bağlı gelişebileceği gibi malignite, kronik böbrek yetmezliği, kardiyovasküler hastalıklar, enfeksiyon hastalıkları, bağ doku hastalıkları gibi farklı klinik durumlara da eşlik edebilir. Çalışmamızda Gaziantep bölgesinde PE tespit edilen hastaların klinik özellikleri ve tedavilerinin değerlendirilmesi amaçlanmıştır. Kardiyoloji kliniğine Ocak 2010 ile Ocak 2011 tarihleri arasında başvuran ve transtorasik ekokardiyografisinde PE saptanan 132 hastanın verileri geriye dönük olarak değerlendirildi. Hastaların özgeçmişi, ekokardiyografi, laboratuvar bulguları ve uygulanan tedavi yöntemleri kaydedildi. Hastaların yaş ortalaması 51±17 (17-86) idi. Kadın ve erkekte eşit sıklıkta görüldü (66/66). PE olan hastalarda en sık karşılaşılan öncelikli şikayet nefes darlığı (%73.5) idi. Ekokardiyografide ise en sık hafif düzeyde (
Clinical, laboratory, and echocardiographic features of patients with pericardial effusion in Gaziantep region
Pericardial effusion (PE) is called that increase in the amount of fluid between the pericardium surrounding the heart. PE may be due to primary pericardial diseases, or associated with different clinical situations such as malignancy, chronic renal failure, cardiovascular diseases, infectious diseases. In our study, patients with PE present in the Gaziantep region to evaluate the clinical characteristics and treatment. 132 patients, having PE on transthoracic echocardiography, admitted to the cardiology clinic between January 2010 and January 2011, were retrospectively reviewed data. Background, echocardiography, laboratory findings, and treatment of the patients were recorded. The average age of the patients was 51 ± 17 (17-86) year. It was observed with equal frequency in males and females (66/66). The most common primary complaint of patients with PE were dispne(73.5%). Mild PE (
___
- 1. Bıyık İ, Ergene O. Kronik Perikardiyal Efüzyonda Tanı ve Tedavi Yaklaşımı.Türk Kardiyol Dern Arş. 2004;32:581-590.
- 2. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y, et al; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25:587-610.
- 3. Allan LK, Craig RA: Diseases of thepericardium, restrictivecardiomyopathyanddiastolicdisfunction. Topol EJ(ed). Textbook of CardiovascularMedicine. Philadelphia, Lippincott Williams Wilkins. 2002:614-616.
- 4. Gümrükçüoğlu HA, Akyol A, Tuncer M, Güneş Y, Beğenik H, Akdağ S, et al. Perikart efüzyonu olan hastaların klinik ve laboratuvar özellikleri. Türk Kardiyol Dern Ars. 2010;38:473- 479.
- 5. Seferovic PM, Ristic AD, Maksimovic R, Simeunovic DS, Milinkovic I, et al. Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev. 2012. [Baskıda]
- 6. Pawlak Cieslik A, Szturmowicz M, Fijałkowska A, Gatarek J, Gralec R, Błasinska Przerwa K, et al. Diagnosis of malignant pericarditis: a single centre experience. Kardiol Pol. 2012;70:1147-1153.
- 7. Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53:157-163.
- 8. Becit N, Unlü Y, Ceviz M, Koçogullari CU, Koçak H, Gürlertop Y. Subxiphoid pericardiostomy in the management of pericardial effusions: case series analysis of 368 patients. Heart. 2005;91:785-790.
- 9. Markovic NS, Dimkovic N, Damjanovic T, Loncar G, Brajovic M, Dimkovic S. Correlation between the inferior vena cava collapsibility and asymptomatic pericardial effusion in hemodialysis patients. Med Pregl. 2007;60 Suppl 2:165-169.
- 10. Mathenge RN, McLigeyo SO, Muita AK, Otieno LS. The spectrum of echocardiographic findings in chronic renal failure. East Afr Med J. 1993;70:107-111.
- 11. Yu SB, Zhao QY, Huang H, Chen DE, Cui HY, Qin M et al. Prognosis investigation in patients with chronic heart failure and pericardial effusion. Chin Med J (Engl). 2012;125:882-887.
- 12. Bucekova E, Simkova I, Hulman M. Postpericardiotomy syndrome - post-cardiac injury syndrome. Bratisl Lek Listy. 2012;113:481-485.
- 13. Bocsi J, Hambsch J, Osmancik P, Schneider P, Valet G, Tarnok A. Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data. Crit Care. 2002;6:226- 233.
- 14. Imazio M, Brucato A, Rovere ME, Gandino A, Cemin R, Ferrua S, et al. Colchicine prevents early postoperative pericardial and pleural effusions. Am Heart J. 2011;162:527-532.e1.
- 15. Ozer HO, Davutoğlu V, Cakici M, Doğan A, Sari I, Oylumlu M, et al. Ekokardiyografi rehberliğinde apikal yaklaşımla perikardiyosentez. Türk Kardiyol Dern Ars. 2009;37:177-181.
- 16. Sagrista-Sauleda J, Merce AS, Soler-Soler J. Diagnosis and management of pericardial effusion. World J Cardiol. 2011;3:135-143.
- 17. Jeong TD, Jang S, Park CJ, Chi HS. Prognostic relevance of pericardial effusion in patients with malignant diseases. Korean J Hematol. 2012;47:237-238.